Skip to main content
GutCited

Descrizione

Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.

Cite This Figure

![Figure 11: Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.]()

> Source: Kadur Ramamurthy Raveendra et al. "An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dys." *Evidence-based complementary and alternative medicine : eCAM*, 2012. PMID: [21747893](https://pubmed.ncbi.nlm.nih.gov/21747893/)
<figure>
  <img src="" alt="Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period." />
  <figcaption>Figure 11. Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.<br>  Source: Kadur Ramamurthy Raveendra et al. "An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dys." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2012. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/21747893/">21747893</a></figcaption>
</figure>